Opus Genetics (IRD) EBITDA Margin (2010 - 2026)
Opus Genetics (IRD) reported EBITDA Margin of -2180.93% for Q2 2026, down 1872.39 percentage points from -308.54% a year earlier and down 1515.60 percentage points from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Opus Genetics' EBITDA Margin came in at -512.94%, down 92.50 percentage points year-over-year; for FY2025, it came in at -271.53%, up 293.10 percentage points from FY2024.
- EBITDA Margin has a four-year change of +3582.63 percentage points (FY2021 to FY2025).
- By year, EBITDA Margin came in at -564.63% in FY2024 (-509.21 pp), -55.42% in FY2023 (-101.17 pp), 45.75% in FY2022 (+3899.91 pp) and -3854.16% in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBITDA Margin since Q2 2021.
- Year over year, EBITDA Margin gained in three of the last eight quarters, with an average year-over-year change of -243.12 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2025 (a gain of 587.76 percentage points); the low point was Q2 2026 (a drop of 1872.39 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -665.32% (Q1 2026), -295.99% (Q4 2025) and -269.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Opus Genetics | 409.11 Mn | 184.39 Mn | - | -2,180.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,180.93% |
| Mar 31, 2026 | -665.32% |
| Dec 31, 2025 | -295.99% |
| Sep 30, 2025 | -269.50% |
| Jun 30, 2025 | -308.54% |
| Mar 31, 2025 | -226.91% |
| Dec 31, 2024 | -883.75% |
| Sep 30, 2024 | -207.11% |
| Jun 30, 2024 | -748.92% |
| Mar 31, 2024 | -450.50% |
| Dec 31, 2023 | -320.88% |
| Sep 30, 2023 | 53.51% |
| Jun 30, 2023 | -146.65% |
| Mar 31, 2023 | -350.49% |
| Dec 31, 2022 | 85.85% |
| Sep 30, 2021 | -865.24% |
| Jun 30, 2021 | -7,136.00% |
| Mar 31, 2020 | -237.02% |
| Jun 30, 2010 | -16,946.03% |
API Access
Opus Genetics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();